BLUE BELL, PA — Mitochon Pharmaceuticals received a $1 million clinical trial award from the ALS Association to help fund a 24-week Phase 2 study of its experimental drug MP-101 …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.